Gefticip 250 Mg

Gefticip 250 Mg

Gefticip 250 Mg Tablet is an anticancer medicine which is used in the treatment of cancer of the lungs. It should only be used under the supervision of a qualified physician. This medicine is not recommended for use in patients with lung and liver diseases.

Drug = Gefitinib

Strength = 250 Mg

Manufacturer = Cipla Ltd.

How To Take

Take Gefticip 250 Mg in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gefticip 250 Mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Dosage

Gefticip 250 Mg

Side Effects

Nausea

Rash

Vomiting

Weakness

Loss of appetite

Dry skin

Diarrhea

Stomatiti

Warning

Gefticip 250 Mg Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

Gefticip 250 Mg Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.

Gefticip 250 Mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Gefticip 250 Mg Tablet may be needed. Please consult your doctor.

Gefticip 250 Mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gefticip 250 Mg Tablet may not be needed in these patients. Please consult your doctor.

Uses

Gefticip 250 Mg is used to treat lung cancer. It works by slowing or stopping the growth of cancer cells. Gefticip 250 Mg blocks a certain protein (an enzyme called tyrosine kinase)